Xinyu Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based on research and development and production of microbiological drugs, the National High-tech Enterprise, Anhui Province's first batch of technology innovation enterprises, Anhui Province's production, education and research demonstration enterprises, Anhui Province AAA credit enterprises. The company covers an area of 500 mu, with the total assets of 1 billion yuan.

Company Products: Lincomycin Hydrochloride, Clindamycin Phosphate, Clindamycin Hydrochloride, Moxidectin, Doramectin, Neomycin Sulfate, Framectin Sulfate, Tenovir Fumarate, Canamycin Series, Naceptide Premix, Enlamycin Premix, Acarbose, Tomoxetine Hydrochloride, Linezolid, Natural calcium folate and other active pharmaceutical ingredients.

The company has established a sound quality assurance system, all production lines have passed the national GMP certification. The company is set up as the pharmaceutical GMP practice training base by Anhui Provincial Food and Drug Administration. Lincomycin hydrochloride production line has passed America FDA certification, German GMP certification, Spain, Canada, Japan and other countries registered. Lincomycin hydrochloride, clindamycin phosphate obtained CEP certificate. The company leads the development of enterprises by scientific and technological innovation, and has set up provincial research and development institutions such as Anhui Enterprise Technology Center, Anhui Microbial Drug Engineering Research Center and Postdoctoral Scientific Research Workstation. It has been rated as a key high-tech enterprise of the National Torch Program, and has undertaken 3 projects of the National Torch Program, 26 authorized patents, 1 provincial core patent industrialization demonstration project, and 1 provincial major science and technology special research project. The main products, Lincomycin hydrochloride and Clindamycin phosphate , were respectively awarded the Excellent Patent Award of Anhui Province. Naceptide Premix was awarded the title of "National Key New Product" and Clindamycin Phosphate  was awarded the title of "Anhui Industrial Fine Product".

The company adheres to the market-oriented, operation-centered, and strictly implements the standardized management. The production level and market share of the products are at the forefront in China. The company has stable domestic high-quality customers, high-end foreign customers, with customers all over the world.

The company upholds the "integrity first, service for the public, responsible for the life" business purposes, based on the enterprise spirit of "pursue outstanding, endless", wholeheartedly for the domestic and foreign merchants to provide quality products and excellent service, is willing to work with colleagues from all walks of life to establish friendly and cooperative partnership, jointly make unremitting efforts to promote the development of medicine!